BamSEC and AlphaSense Join Forces
Learn More

Enzon Pharmaceuticals Inc – Indentures

OTC: ENZN    
Share price (3/12/26): $0.06    
Market cap (3/12/26): $4.267 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 425 3 pages Ninth Amendment to the Section 382 Rights Agreement by and Between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Rights Agent
12/34/56
EX-4.1
from 8-K 3 pages Ninth Amendment to the Section 382 Rights Agreement by and Between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Rights Agent
12/34/56
EX-4.1
from 10-K 6 pages Description of Enzon Pharmaceuticals, Inc.’s Registered Securities
12/34/56
EX-4.1
from 8-K 3 pages Eighth Amendment to the Section 382 Rights Agreement by and Between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Rights Agent
12/34/56
EX-4.1
from 425 3 pages Eighth Amendment to the Section 382 Rights Agreement by and Between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Rights Agent
12/34/56
EX-4.1
from 8-K 3 pages Seventh Amendment to the Section 382 Rights Agreement by and Between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Rights Agent
12/34/56
EX-4.1
from 8-K 3 pages Sixth Amendment to the Section 382 Rights Agreement by and Between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Rights Agent
12/34/56
EX-4.1
from 8-K 3 pages Fifth Amendment to the Section 382 Rights Agreement by and Between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as Rights Agent
12/34/56
EX-4.1
from 10-Q 3 pages Fourth Amendment to The
12/34/56
EX-4.1
from 8-K 3 pages Third Amendment to the Section 382 Rights Agreement by and Between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company as Rights Agent
12/34/56
EX-4.1
from 10-K 6 pages Description of Enzon Pharmaceuticals, Inc.’s Registered Securities
12/34/56
EX-4.1
from 8-K 3 pages Second Amendment to the Section 382 Rights Agreement by and Between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company as Rights Agent
12/34/56
EX-4.1
from 10-K 5 pages Description of Enzon Pharmaceuticals, Inc.’s Registered Securities
12/34/56
EX-4.1
from 10-K 5 pages Description of Enzon Pharmaceuticals, Inc.’s Registered Securities
12/34/56
EX-4.1
from 10-K 5 pages Description of Enzon Pharmaceuticals, Inc.’s Registered Securities
12/34/56
EX-4.1
from 8-K 3 pages First Amendment to the Section 382 Rights Agreement by and Between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company as Rights Agent
12/34/56
EX-4.1
from 10-K 5 pages Description of Enzon Pharmaceuticals, Inc.’s Registered Securities
12/34/56
EX-4.3
from S-1/A 2 pages Transferrable Subscription Rights Certificate Evidencing Transferable Subscription Rights of Enzon Pharmaceuticals, Inc., With Every 1,105 Subscription Rights Held Entitling the Holder to Purchase One Unit. Each Unit Consists of One Share of Newly Designated Series C Preferred Stock, Par Value $0.01 Per Share (The “Preferred Stock”), and 750 Shares of Common Stock. Subscription Price: $1,090 Per Unit the Subscription Rights Will Expire if Not Exercised on or Before 5:00 P.M., New York City Time, on [ ], 2020, Subject to Extension or Earlier Termination
12/34/56
EX-4.2
from S-1/A 17 pages Subscription and Escrow Agent Agreement Between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company
12/34/56
EX-4.1
from 8-K 66 pages Section 382 Rights Agreement Dated as of August 14, 2020 by and Between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company as Rights Agent
12/34/56